OM

Opaleye Management Portfolio holdings

AUM $494M
This Quarter Return
+30.02%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$201M
AUM Growth
+$201M
Cap. Flow
+$6.28M
Cap. Flow %
3.13%
Top 10 Hldgs %
56.18%
Holding
53
New
13
Increased
15
Reduced
7
Closed
9

Top Buys

1
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
$7.84M
2
IMMU
Immunomedics Inc
IMMU
$6.21M
3
OCUL icon
Ocular Therapeutix
OCUL
$4.24M
4
CTMX icon
CytomX Therapeutics
CTMX
$2.94M
5
ZSAN
Zosano Pharma Corporation
ZSAN
$2.38M

Top Sells

1
ARIA
Ariad Pharmaceuticals Inc
ARIA
$12.4M
2
NGNE icon
Neurogene
NGNE
$3.75M
3
MGNX icon
MacroGenics
MGNX
$3.48M
4
OMER icon
Omeros
OMER
$2.63M
5
CLSD icon
Clearside Biomedical
CLSD
$2.41M

Sector Composition

1 Healthcare 92.1%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZSAN
26
DELISTED
Zosano Pharma Corporation
ZSAN
$2.38M 1.18%
+1,786
New +$2.38M
VIRX
27
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.26M 1.12%
+15,714
New +$2.26M
WVE icon
28
Wave Life Sciences
WVE
$1.27B
$2.15M 1.07%
+78,300
New +$2.15M
GNMX
29
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$1.99M 0.99%
1,070,000
-430,000
-29% -$800K
PTLA
30
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.96M 0.98%
+50,000
New +$1.96M
IOVA icon
31
Iovance Biotherapeutics
IOVA
$800M
$1.71M 0.85%
230,000
-70,000
-23% -$521K
XENE icon
32
Xenon Pharmaceuticals
XENE
$2.99B
$1.44M 0.72%
360,000
-45,000
-11% -$180K
NGNE icon
33
Neurogene
NGNE
$284M
$1.42M 0.71%
4,250
-11,250
-73% -$3.75M
ABEO icon
34
Abeona Therapeutics
ABEO
$356M
$1.38M 0.68%
11,000
-5,000
-31% -$625K
TNXP icon
35
Tonix Pharmaceuticals
TNXP
$243M
– –
0
– –
CDTX icon
36
Cidara Therapeutics
CDTX
$1.61B
$955K 0.48%
+6,125
New +$955K
ALBO
37
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$876K 0.44%
+36,500
New +$876K
KPTI icon
38
Karyopharm Therapeutics
KPTI
$61.4M
$770K 0.38%
+4,000
New +$770K
CORI
39
DELISTED
Corium International, Inc.
CORI
$677K 0.34%
162,000
-218,000
-57% -$911K
ARQL
40
DELISTED
Arqule Inc
ARQL
$593K 0.3%
+560,000
New +$593K
SYRS
41
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$400K 0.2%
+2,515
New +$400K
XOMA icon
42
Xoma
XOMA
$421M
$287K 0.14%
+40,400
New +$287K
BLRX
43
BioLineRX
BLRX
$15.5M
$240K 0.12%
417
– –
CLSD icon
44
Clearside Biomedical
CLSD
$26.7M
– –
-270,000
Closed -$2.41M
MGNX icon
45
MacroGenics
MGNX
$121M
– –
-170,000
Closed -$3.48M
OMER icon
46
Omeros
OMER
$284M
– –
-265,300
Closed -$2.63M
KA
47
DELISTED
Kineta, Inc. Common Stock
KA
– –
-1,071
Closed -$1.84M
AGRX
48
DELISTED
Agile Therapeutics, Inc
AGRX
– –
-8
Closed -$85K
TRIL
49
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-110,000
Closed -$622K
AKAO
50
DELISTED
Achaogen, Inc.
AKAO
– –
-80,000
Closed -$1.04M
1
2
3